Five Questions With: Edward G. Bozzi
A new industry cluster group, the Rhode Island BioScience Leaders, was recently formed, bringing together the leaders of 20 small- to medium-sized bioscience companies in Rhode Island. The idea for the group came from Denice Spero, co-director of iCubed, and Edward G. Bozzi, an assistant clinical professor in URI’s Biotechnology Manufacturing program. The goal is build a collaborative force to advocate on behalf of the cluster’s needs. Providence Business News asked Bozzi to talk about the group’s strategies moving forward.
PBN: What prompted you to organize a new group of 20 Rhode Island bioscience companies?
BOZZI: After meeting with the CEO of a biotechnology company this past summer who was searching for new space and was not aware that another firms had available space, it occurred to me that the biotechnology companies of modest size in the metro Providence area do not know much about each other.
I felt that they would benefit greatly if they were aware of each other’s facilities, technology and capabilities. I discussed this situation with Denice Spero, co-director of the University of Rhode Island’s Institute for Immunology and Informatics (iCubed), who had similar ideas that these bioscience companies should somehow be connected.
So, together we initiated a exploratory meeting at iCubed in September of 2012 and found that the leaders of the 20 bioscience firms in the metro Providence were eager to collaborate.
From URI’s perspective it would be important that these bioscience firms grow to provide internships and jobs for our biotechnology students. In addition, the type of collaboration that is already occurring between iCubed and member company, ProThera Biologics, might be extended for the mutual benefit of all.
PBN: How is the new bioscience cluster different from other life science companies?
BOZZI: The Rhode Island BioScience Leaders (RI BSL) group differs from other life science organizations in terms of…
>>>FULL PBN ARTICLE HERE<<<